/
SNNAQ
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of revenue | $32.0K | $67.0K | $120.0K | $157.0K |
| Gross profit | −$32.0K | −$67.0K | −$120.0K | −$157.0K |
| Gross margin | — | — | — | — |
| R&D | $2.4M | $11.0M | $30.5M | $51.6M |
| Operating income | −$11.1M | −$20.7M | −$48.6M | −$76.5M |
| EBITDA | −$11.1M | −$20.6M | −$48.5M | −$76.3M |
| Net income | −$11.3M | −$21.8M | −$50.5M | −$73.3M |
| Net margin | — | — | — | — |
| EPS (diluted) | -5.81 | -11.23 | -5.19 | -3.59 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.77
Price
$0.00
Implied upside
+76869271%
Peer comparison
SIENNA BIOPHARMACEUTICALS
SIENNA BIOPHARMACEUTICALS
Held by traders on TradeandTell
No one on the platform currently holds SNNAQ.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in SNNAQ as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded SNNAQ yet.